Select Research Topics
A curated selection of insights from the Maven Bio platform.
Top 15 Drugs by Worldwide Sales in 2023
The list of the world's 15 top selling drugs in 2023 is led by Merck's oncology powerhouse Keytruda, which achieved a record of $25 billion in revenue last year.
March 22, 2024
Race for GLP-1 Obesity Drugs Heats Up
13 years after Roche halted its GLP-1 drug trials due to side effects, it's making a $3.1B acquisition to get back in the weight loss game.
January 20, 2024
How Drug Pricing in the US Compares to Other Countries
New weight loss drugs like Ozempic, Wegovy and Zepbound have been on fire - but how does pricing in the US compare to other countries? It’s no secret that drugs cost more in the US than in other developed economies, and the Inflation Reduction Act’s provision to allow Medicare to negotiate drug prices has reignited that debate.
January 20, 2024
Big Pharma Partnerships in 2023: A Comprehensive Overview
Facing a landscape where many blockbuster drugs are nearing or have reached the end of their exclusivity, large biopharma leaders are increasingly turning to collaborations to refill their pipelines with promising therapeutics.
January 19, 2024
Page 7 of 7